• Claritas Announces $15m Funding Round

    Bio-IT World News Brief | Claritas Genomics announced today that it has secured $15 million in capital for its Series B round to expand its commercial operations, launch new next generation sequencing-based tests for diagnosis of pediatric genetic disorders and continue to build its network of clinical pediatric disease experts. 

    Jan 26, 2015

  • Yeast as a Model for Neurodegenerative Disease?

    Xconomy | Yumanity, a well-connected drug discovery startup, plans to play the long game in drug development by using yeast models in deep phenotypic screens to study neurological diseases based on protein misfolding.

    Jan 26, 2015

  • Appistry Launches CloudDx Translational from NIH Tool

    Bio-IT World News Brief | Appistry today launched Appistry CloudDx Translational, a “sister product” to the CloudDx platform launched last June, now renamed CloudDx Clinical.

    Jan 26, 2015

  • Early Data on Human Sequencing with Oxford Nanopore MinION

    Bio-IT World News Brief | A team based at the University of Toronto has published the first reported case of using the Oxford Nanopore MinION to sequence human DNA, in a study focused on three genes with known relevance to drug dosing.

    Jan 22, 2015

  • Aspera's Michelle Munson Joins GenoSpace Board

    Bio-IT World News Brief | GenoSpace announced this morning that Michelle Munson, CEO of Aspera, an IBM Company, has joined its board as an independent director.

    Jan 22, 2015

  • Next Generation Solution for Forensic DNA Testing

    Bio-IT World News Brief | Illumina today released its MiSeq FGx instrument, a version of the company's MiSeq next generation sequencer modified for forensic DNA testing, as well as ForenSeq chemistry and software kits.

    Jan 21, 2015

  • President Obama Heralds New Precision Medicine Initiative in State of the Union

    Bio-IT World | Commentators from around the science and healthcare world react to President Obama's announcement, in last night's State of the Union address, that his new budget will propose a Precision Medicine Initiative to support research into individualized therapies based on patients' unique genetic and molecular profiles.

    Jan 21, 2015

  • SV Bio Relaunched as Lifecode, Maker of LDTs

    Bio-IT World | SV Bio today announced a new name, a new focus, and a new product: a next generation sequencing (NGS)-based oncology assay, the Pan Cancer Somatic Panel (PCSP).

    Jan 20, 2015

  • Biotech Boom or Biotech Bubble?

    New York Times | "I have my seatbelt and crash helmet on," a biotech CEO tells The New York Times in an investigation of soaring biotechnology stocks and drug approvals in the wake of last week's J.P. Morgan Healthcare Conference.

    Jan 20, 2015

  • LifeMap Releases NGS Phenotyper

    Bio-IT World Product Brief | LifeMap Sciences has released VarElect, an application that David Warshawsky, CEO of the company, calls a next-generation sequencing phenotyper. The tool leverages LifeMap’s integrated biomedical knowledgebase and discovery platform for biomedical research, which includes GeneCards human gene database; MalaCards human disease database; and LifeMap Discovery, the database of embryonic development, stem cell research, and regenerative medicine.

    Jan 20, 2015